Alerts Sign-up
Doctors at the Florence Wormald Heart & Vascular Institute at St. Elizabeth Healthcare have successfully performed the first implantation of the AVEIR DR™ Dual Chamber Leadless Pacemaker (LP) System in the Greater Cincinnati region. The procedure was carried out by Dr. Mohamad Sinno, a cardiac electrophysiologist at St. Elizabeth Healthcare, on April 1, 2024.
The AVEIR DR™ LP System, developed by Abbott and approved by the FDA in 2023, is designed to address abnormal or slow heart rhythms known as arrhythmia. Arrhythmia can lead to serious health issues such as stroke and heart failure if not treated.
This new pacemaker system eliminates the need for leads or wires and avoids chest incisions for generator placement. It consists of an atrial leadless pacemaker (AVEIR™ AR LP) and a ventricular leadless pacemaker (AVEIR™ VR LP), enabling pacing and sensing in both heart chambers. Physicians have the option to start with either an atrial or ventricular device alone and add a second pacemaker for dual chamber support if required.
“Physicians need the flexibility to adjust treatment as patient needs evolve,” said Dr. Sinno. “This device enables us to do just that for our cardiac patients while also eliminating common complications associated with traditional pacemakers, including infection, lead fracture, insulation problems, skin erosion and keloid formation.”
Post-implantation, patients experience no visible scarring and face no restrictions on arm movement, which enhances their short-term recovery compared to those with traditional pacemakers.
“We’re proud to lead the way in the Greater Cincinnati region by offering this life-saving device,” said Dr. D.P. Suresh, Executive Medical Director of the Florence Wormald Heart & Vascular Institute at St. Elizabeth. “We are committed to providing our patients with the latest technology and treatments, and the AVEIR DR™ is a prime example of our dedication to advancing patient care and experience.”
